When reporting earnings Thursday, Lilly said it brought in total revenue of $17.6 billion in the third quarter, greater than the $16.1 billion predicted by analysts
It is expected to be approved by federal health officials for weight loss by the end of the year
Overview of Clinical Trial Study 1 (NCT03574597) was a multi-national, multi-center, placebo-controlled, double-blind trial to determine the effect of WEGOVY relative to placebo on major adverse cardiovascular events (MACE) when added to current standard of care, which included management of CV risk factors and individualized healthy lifestyle counseling (including diet and physical activity)
Before prescribing semaglutide, a clinician may review: height, weight and BMI waist measurement where relevant weight-related health conditions previous weight-management treatments prescription and non-prescription medicines diabetes history and blood-glucose treatment gastrointestinal symptoms pancreatitis and gallbladder history pregnancy and contraception eating-disorder history relevant medical records or blood-test results treatment expectations long-term weight-management goals The consultation is not simply intended to determine whether a patient meets a BMI threshold
Other Medications Certain chemotherapies, steroids, hormonal medications like anti-estrogen treatments, antidepressants, or antipsychotics are known to cause weight gain
In summary: Ozempic face is simply the deflation of subcutaneous fat in the face
